Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IMAC Holdings, Inc. BACK

Healthcare  —  Medical Care Facilities
0.00 0.00 NaN as of 25 Sep
Market cap
$150.0K
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

IMAC Holdings, Inc. (BACK) Business Profile

Updated before January 2025

Company Overview

IMAC Holdings, Inc. (NASDAQ: BACK) is a healthcare company specializing in innovative medical advancements and care. Founded in 2015, the company is headquartered in Brentwood, Tennessee. IMAC Holdings was established with the mission of providing non-invasive, regenerative, and restorative healthcare solutions to improve patients’ quality of life. The company operates a network of outpatient medical clinics that focus on delivering treatments for musculoskeletal conditions, including back pain, knee pain, and other joint-related issues.

The leadership team at IMAC Holdings is composed of experienced professionals in the healthcare and business sectors. The company’s CEO, Jeffrey S. Ervin, has been instrumental in driving the organization’s growth and strategic direction. Under his leadership, IMAC has expanded its footprint across the United States, offering a unique blend of regenerative medicine, physical therapy, and minimally invasive procedures.

Core Business Segments

IMAC Holdings operates through several core business segments, each designed to address specific healthcare needs:

Regenerative Medicine

IMAC specializes in regenerative medicine treatments that aim to repair damaged tissues and reduce pain without the need for surgery. Key offerings include:

  • Stem Cell Therapy: Utilizing stem cells to promote tissue regeneration and healing.
  • Platelet-Rich Plasma (PRP) Therapy: A treatment that uses a patient’s own blood components to accelerate healing.

Physical Therapy and Rehabilitation

The company provides comprehensive physical therapy and rehabilitation services to help patients recover from injuries and improve mobility. Services include:

  • Customized Physical Therapy Plans: Tailored programs to address individual patient needs.
  • Post-Surgical Rehabilitation: Helping patients regain strength and functionality after surgery.

Minimally Invasive Procedures

IMAC offers minimally invasive treatments for chronic pain and musculoskeletal conditions. These procedures are designed to provide relief without the risks associated with traditional surgery. Key services include:

  • Joint Injections: Targeted treatments to reduce inflammation and pain.
  • Spinal Decompression Therapy: Non-surgical solutions for back pain relief.

Wellness and Preventative Care

IMAC also focuses on wellness and preventative care to help patients maintain long-term health. Services in this segment include:

  • Nutritional Counseling: Guidance on diet and lifestyle changes to support overall health.
  • Fitness Programs: Exercise regimens designed to improve strength and flexibility.

Business Model

IMAC Holdings operates a vertically integrated business model that combines regenerative medicine, physical therapy, and minimally invasive procedures under one roof. This approach allows the company to offer a comprehensive range of services to its patients, ensuring continuity of care and better outcomes.

Revenue generation primarily comes from patient services, including consultations, treatments, and therapy sessions. The company also partners with insurance providers to make its services accessible to a broader audience. Additionally, IMAC has been exploring opportunities to expand its revenue streams through strategic partnerships and the development of proprietary treatment protocols.

Strategic Direction

IMAC Holdings has outlined a clear strategic direction aimed at driving growth and innovation in the healthcare sector. Key initiatives include:

Expansion of Clinic Network

The company plans to increase its presence across the United States by opening new clinics in underserved markets. This expansion will enable IMAC to reach more patients and grow its revenue base.

Focus on Innovation

IMAC is committed to advancing its treatment offerings through research and development. The company is exploring new regenerative medicine techniques and technologies to enhance patient outcomes.

Sustainability Goals

IMAC aims to integrate sustainable practices into its operations, including reducing waste and optimizing resource use in its clinics.

Diversification of Services

The company is considering the introduction of new product categories, such as telemedicine services and wellness programs, to meet the evolving needs of its patients.

Competitive Landscape

IMAC Holdings operates in a competitive healthcare market, facing competition from both traditional medical providers and specialized clinics. Key competitors include:

  • HCA Healthcare: A leading provider of healthcare services with a broad network of hospitals and clinics.
  • Select Medical Holdings: Specializes in rehabilitation and physical therapy services.
  • Orthopedic Clinics: Independent clinics offering similar regenerative and minimally invasive treatments.

Despite the competition, IMAC differentiates itself through its focus on non-invasive, regenerative solutions and its integrated care model.

Risk Factors

IMAC Holdings faces several risks that could impact its operations and financial performance:

Market Dependence

The company’s revenue is heavily dependent on the demand for its services. Economic downturns or changes in healthcare regulations could affect patient volumes.

Supply Chain Disruptions

IMAC relies on a steady supply of medical equipment and materials. Disruptions in the supply chain could delay treatments and impact revenue.

Competition

The healthcare market is highly competitive, and IMAC must continuously innovate to maintain its market position.

Regulatory Risks

Changes in healthcare laws and regulations could affect the company’s operations and profitability.

Recent Developments

IMAC Holdings has made significant strides in recent years, including:

  • Launch of New Clinics: The company has opened several new locations to expand its reach.
  • Introduction of Telemedicine Services: IMAC has started offering virtual consultations to provide patients with greater access to care.
  • Partnerships with Sports Organizations: Collaborations with professional sports teams to provide specialized treatments for athletes.

Global developments, such as the COVID-19 pandemic, have also influenced IMAC’s operations. The company has adapted by implementing safety protocols and expanding its telemedicine offerings.

Investment Considerations

Strengths

  • Innovative Treatments: Focus on regenerative medicine and minimally invasive procedures.
  • Integrated Care Model: Comprehensive approach to patient care.
  • Growth Potential: Plans for clinic expansion and service diversification.

Risks

  • Market Volatility: Dependence on patient volumes and economic conditions.
  • Regulatory Challenges: Potential changes in healthcare laws.
  • Competition: Pressure from established healthcare providers.

Conclusion

IMAC Holdings, Inc. is a growing player in the healthcare sector, offering innovative treatments and a patient-centric approach. With a clear strategic direction and a commitment to innovation, the company is well-positioned for future growth. However, investors should consider the risks associated with market dependence and regulatory changes. Overall, IMAC’s focus on regenerative medicine and integrated care makes it a compelling option in the healthcare market.